Health scientist and philosopher Marianne Boenink has been appointed professor in Ethics of Healthcare at the Radboud University/ Radboudumc, as of 1 August 2020.
As a professor, Marianne Boenink will focus in particular on ethics of novel biomedical technologies. New technical possibilities in healthcare are often accompanied by visions raising high expectations, like ‘personalized medicine’ and ‘smart healthcare’. One of Marianne’s lines of research deals with the analysis of such visions of the future: how do they shift ideas about health, disease and good care? A second line of work is focused at specific innovations. For example: what does it mean - for patients, professionals and society- if predictions of who will get a disease and how it will evolve become ever more reliable? Marianne Boenink will investigate the ethical desirability of such technological developments.
Following her training as a health scientist in Maastricht, Marianne Boenink (Zelhem, 1965) studied philosophy at the University of Amsterdam. Here she also completed a PhD on the ways in which philosophical and literary texts shape readers’ thinking about normative questions. Her continued fascination with the world of healthcare subsequently led her to a postdoc project exploring ethical issues in predictive genetic testing. As an assistant/associate professor at the University of Twente Marianne’s research was fully oriented towards the question how novel biomedical technologies can be developed and implemented in a responsible manner.
Marianne Boenink is a member of the department of IQ Healthcare. She is an ethical advisor for several European research projects and also is a member of the regional Ethical Review Board for medical research with humans, CMO Arnhem/Nijmegen.
Related news items
Radboud Young Academy safeguards the future of science21 January 2021
New platform to provide advice on policy, create an interdisciplinary network of early career scientists, and promote career development.read more
Increase radio- and immunotherapy efficacy by targeting hypoxia21 January 2021
In a paper recently accepted by Clinical Cancer Research, Daan Boreel, together with Paul Span, Sandra Heskamp, Gosse Adema and Jan Bussink, reviews the therapeutic potential of decreasing the lack of oxygen (hypoxia) often found in solid tumors.read more
Radiation boost lowers risk of prostate cancer recurrence21 January 2021
An additional external-beam radiation dose delivered directly to the tumor can benefit the prospects of men with non-metastatic prostate cancer, without causing additional side effects. The risk of relapse within five years for these men is smaller than for men who did not receive this boost.read more
New research through grants for Radboudumc researchers14 January 2021
Several researchers at the Radboudumc have received grants to start new studies, including on rare diseases, liver disease and cancer metastases. These are grants from the Dutch Research Council, European Joint Programme on Rare Diseases and the Gastric Liver Disease Foundation.read more
Should we prepare for a corona-related depression wave? Indira Tendolkar and Eric Ruhé talk about their research projects13 January 2021
Since the outbreak of the SARS-CoV-2, many of us have been staying at home in order to limit our social interactions, to keep ourselves and others safe from the virus. Yet, there’s also concern about what social distancing and anxiety generated by media reports are doing to people's mental health.read more
RIMLS online award ceremony proudly presenting the winners13 January 2021
In this special webinar of the RIMLS New Year Celebration, scientific director René Bindels reviewed 2020 and looked forward to 2021. But more importantly a number of researchers received prizes in the traditional RIMLS awards ceremony.read more